How to Stop Vaginal Dryness: Treatments That Work

Vaginal dryness responds well to treatment, and most people have several effective options to choose from depending on the cause, their health history, and how severe the symptoms are. For dryness tied to menopause, local estrogen applied directly to the vagina is considered the most effective and best-studied approach, but over-the-counter moisturizers, non-hormonal prescriptions, and newer procedural treatments all have supporting evidence. The real challenge is not a shortage of treatments but figuring out which one fits your situation, because the right choice shifts considerably based on why the dryness is happening in the first place.

Why Vaginal Dryness Happens

The most common driver is a drop in estrogen. When estrogen declines, the vaginal lining thins, loses elasticity, and produces less moisture. The cells that line the vagina shift from a healthy mix to one dominated by less mature cell types, and the population of protective lactobacilli drops off, raising vaginal pH and leaving the tissue more fragile and dry.¹ This process is most familiar in the context of menopause, but it can also happen during breastfeeding, after certain cancer treatments, or while taking medications that suppress estrogen.

Menopause is not the only culprit, though. Autoimmune conditions like Sjögren’s syndrome cause vaginal dryness through a completely different pathway. Research on women with primary Sjögren’s found that their dryness could not be explained by the typical thinning and pH changes seen in menopause. Instead, immune cells infiltrated the vaginal wall and the number of vascular smooth muscle cells dropped, pointing to blood-vessel dysfunction as the cause.² Follow-up work has linked increased interferon signaling in vaginal tissue to the inflammation driving that dysfunction.³ This distinction matters practically: estrogen-based treatments will not address dryness caused by immune-mediated vascular problems.

Other contributors include frequent vaginal douching, which has been associated with dryness, irritation, and disrupted vaginal flora.⁴ Certain medications, including antihistamines and some antidepressants, can reduce moisture throughout the body, including vaginal tissue. If dryness appeared shortly after starting a new medication or alongside other symptoms like dry eyes and dry mouth, that pattern is worth mentioning to a clinician.

Over-the-Counter Lubricants and Moisturizers

For many people, the first line of treatment is something you can buy without a prescription. Lubricants and moisturizers are not the same thing, and understanding the difference helps you use them properly. Lubricants are applied during sexual activity to reduce friction. Moisturizers are used regularly, typically every few days, to rehydrate vaginal tissue and provide ongoing relief from dryness symptoms. The two can be used together, and either can be layered on top of hormone therapy if you are using it.⁵

Not all lubricants are created equal, and some popular products have a safety problem that rarely gets discussed. The World Health Organization recommends that vaginal lubricants stay below a certain osmolality threshold to avoid damaging tissue. When researchers tested twelve commercially available lubricants, seven exceeded the WHO’s recommended maximum, and four of those were roughly three times over the acceptable limit.⁶ Why does this matter? Highly concentrated (hyperosmolal) lubricants pull water out of vaginal cells, which damages the tissue barrier. Lab studies using a three-dimensional vaginal model showed that hyperosmolal lubricants caused significantly more epithelial damage, potentially increasing susceptibility to infections by making the tissue “leaky” and by harming the lactobacilli that help protect against pathogens.⁷

When shopping for a lubricant or moisturizer, look for products that are iso-osmolal or close to it, and avoid those with glycerin high on the ingredient list, since glycerin is one of the main ingredients that pushes osmolality up. Water-based products are generally the safest starting point. Silicone-based lubricants are another option and tend not to have the osmolality issue, though they are harder to wash off and can degrade silicone-based devices.

Local Hormone Therapy

If moisturizers and lubricants are not enough, vaginal estrogen is the treatment with the deepest evidence base. It comes in several forms: creams, tablets, rings, and soft-gel inserts. All deliver estrogen directly to the vaginal tissue, which reverses the thinning, restores moisture, and brings vaginal pH back down toward its premenopausal range. Because the estrogen acts locally, blood levels remain far lower than with systemic hormone therapy. With ultra-low-dose formulations, systemic estradiol levels stay very close to baseline postmenopausal values.⁸

Dose matters significantly for systemic absorption. Higher-dose vaginal estradiol creams do produce a measurable spike in blood estrogen levels within hours of application, while low-dose versions keep the rise minimal.⁹ This is one reason clinicians now favor the lowest effective dose. Standard-dose oral estrogen, the kind used for hot flashes, may not even adequately treat vaginal dryness on its own, since the vaginal tissue often needs more direct and sustained exposure than a systemic pill provides.¹⁰

The safety profile of low-dose vaginal estrogen is reassuring. A pooled analysis of women using ultra-low-dose vaginal estradiol tablets for a full year found no increased risk of endometrial thickening or cancer, consistent with the background rate in postmenopausal women not using any estrogen at all.¹¹ A separate large study confirmed no signs of endometrial stimulation after twelve months of the same regimen.¹² This is important because fear of the risks associated with systemic hormone therapy has historically made both doctors and patients reluctant to use even local estrogen. The evidence suggests those concerns, while understandable, do not apply to low-dose vaginal formulations in the same way.¹³

Intravaginal DHEA (Prasterone)

Prasterone is a vaginal insert containing DHEA, a precursor hormone that the body converts locally into both estrogen and androgens inside the vaginal tissue. It was approved for treating vaginal dryness and painful sex after phase III trials showed it significantly improved cell composition, vaginal pH, and symptom severity compared to placebo.¹⁴ One of the appealing aspects of prasterone is that it works through a local conversion process, and blood levels of sex steroids stayed within normal postmenopausal ranges in trials.¹⁵

Head-to-head comparison data suggest prasterone performs at least as well as low-dose conjugated estrogen cream and low-dose estradiol for reducing dryness and painful intercourse, with the added advantage of not introducing estrogen directly into the bloodstream.¹⁶ For some women, particularly those with estrogen-sensitive conditions, this distinction may make prasterone a more comfortable choice, though individual guidance from a specialist is still advisable in those cases.

Ospemifene, an Oral Alternative

If the idea of inserting anything vaginally is unappealing, ospemifene offers a different route. It is an oral tablet taken once daily that acts on estrogen receptors differently in different tissues. In the vaginal lining, it behaves almost like full estrogen, promoting healthier cell growth and lowering pH. In a phase III trial focused on vaginal dryness, women taking ospemifene were roughly twice as likely to see improvement in dryness severity compared to those on placebo.¹⁷ Earlier trials confirmed its effects on vaginal cell composition and pH as well.¹⁸

Because it is a selective estrogen receptor modulator, ospemifene does not act like full estrogen everywhere in the body. It belongs to the same chemical family as tamoxifen but differs in that it has a strong agonist effect specifically on vaginal tissue.¹⁹ Side effects in trials were mostly mild to moderate. It is not appropriate for everyone, and a healthcare provider can help determine whether it is a reasonable option based on individual risk factors.

Hyaluronic Acid Gels

Hyaluronic acid is a naturally occurring substance that binds large amounts of water and is used widely in skin care and joint injections. Applied vaginally, it serves as a non-hormonal moisturizer with some clinical evidence behind it. A multicenter trial comparing hyaluronic acid vaginal gel to estriol cream found both were effective at relieving vaginal dryness, leading researchers to describe the gel as a valid alternative to estrogen-based treatments.²⁰ Because it does not contain hormones, hyaluronic acid is an option for people who cannot or prefer not to use any form of estrogen.²¹ It is available as both a prescription and in some OTC formulations depending on where you live.

CO2 Laser and Energy-Based Treatments

Fractional CO2 laser treatment has gained attention as a non-pharmaceutical option for vaginal dryness. The procedure delivers controlled heat to the vaginal wall, aiming to stimulate collagen production and improve blood flow and tissue elasticity.²² A systematic review and meta-analysis pooling data from multiple studies found significant reductions in dryness and pain with intercourse after CO2 laser treatment, along with improvements in sexual function scores and no major adverse events.²³

Individual studies paint a similar picture. One prospective study reported that symptoms either resolved entirely or were reduced to minimal levels after treatment, with sexual function scores rising substantially. After treatment, only about one percent of participants still had atrophic tissue readings.²⁴ Safety data has been encouraging too: in a prospective observational study, no severe complications occurred, side effects were minor and transient, and about ninety percent of patients said they would highly recommend the procedure.²⁵

The caveats are real, though. Most laser studies lack long-term follow-up, the treatment typically requires multiple sessions, results may not be permanent, and it can be expensive since insurance rarely covers it. Regulatory agencies in some countries have issued caution about marketing these devices for vaginal rejuvenation without adequate long-term safety data. It is a promising tool, but the evidence base is still catching up to the enthusiasm.

What Changes for Breast Cancer Survivors

Vaginal dryness is extremely common in women who have been treated for breast cancer, partly because of menopause induced by chemotherapy and partly because of anti-estrogen drugs like tamoxifen and aromatase inhibitors used to prevent recurrence. This creates a difficult bind: the most effective treatments for vaginal dryness rely on estrogen, which is exactly what oncologists are trying to suppress.

Guidelines differ on how to handle this. The North American Menopause Society accepts the use of low-dose vaginal estrogen in breast cancer survivors if non-hormonal approaches fail, recommending the lowest effective dose. But the American Cancer Society and American Society of Clinical Oncology have discouraged vaginal estrogen use in women on aromatase inhibitors, and surveys suggest up to seventy percent of oncologists managing breast cancer survivors will not prescribe any hormonal treatments at all.²⁶ Observational data has suggested that local estrogen is relatively safe in this group, but definitive randomized trial data is still lacking.

Non-hormonal topical creams have been studied specifically in women undergoing breast cancer treatment. An open prospective multicenter study found that a non-hormonal cream effectively reduced dryness symptoms in this population over four weeks, though the study design was limited by its short duration and lack of randomization.²⁷ For breast cancer survivors, the practical starting point is typically non-hormonal moisturizers, hyaluronic acid, and lubricants, with escalation to low-dose vaginal estrogen only as a shared decision with an oncologist.

The Microbiome Connection

The health of the vaginal microbiome is closely tied to dryness. In premenopausal women, lactobacilli typically dominate the vaginal environment, producing lactic acid that keeps pH low and pathogens at bay. After menopause, as estrogen falls, lactobacilli decline and a more diverse and less protective bacterial community takes over.²⁸ Research using gene sequencing confirmed this pattern: women with the least dryness had low bacterial diversity dominated by lactobacilli, while women with moderate to severe dryness had markedly fewer lactobacilli and a wider array of other species.²⁹

This relationship appears to run in both directions. Treatments that restore vaginal tissue health also shift the microbiome back toward a lactobacillus-dominant state. A study of women taking ospemifene found that atrophic vaginal tissue was characterized by significantly reduced lactobacilli, and that higher vaginal health scores correlated with greater lactobacillus abundance.³⁰ The implication is that effective treatment of dryness does not just relieve symptoms — it rebuilds a more protective microbial environment.

Pelvic Floor Training and Physical Therapy

Pelvic floor muscle training is not a standalone cure for vaginal dryness, but emerging evidence suggests it may play a supporting role. A pilot randomized controlled study found that baseline pelvic floor function was correlated with dryness severity — women with weaker pelvic floor measurements tended to have worse dryness and burning scores.³¹ A case study also reported improvement in some vaginal atrophy symptoms when pelvic floor training was combined with local estrogen therapy, though the authors noted that more research is needed to confirm those findings and explore what mechanisms are involved.³²

For women dealing with painful sex alongside dryness, pelvic floor physical therapy may be more directly useful. A systematic review of manual therapy for painful intercourse found that all included studies showed significant improvements in pain.³³ The dryness itself may be one contributor to that pain, but tight or dysfunctional pelvic floor muscles are often another. Addressing both the tissue dryness with moisturizers or hormones and the muscular component with physical therapy is a more complete approach than tackling either alone.

When to See Someone About It

Many people tolerate mild dryness for years before seeking help, and surveys have shown that the condition takes a real toll on emotional well-being and intimate relationships for both women and their partners.³⁴ It is worth bringing up with a clinician when OTC products are not providing relief, when dryness is accompanied by bleeding or recurrent infections, when it appeared suddenly or alongside other dryness symptoms like dry eyes, or when it is interfering with sex or daily comfort. A clinical evaluation can combine your description of symptoms with objective measures like vaginal pH, which rises above its normal acidic range when tissue is atrophic.³⁵ That combination of subjective and objective assessment helps pinpoint the cause and steer treatment in the right direction, especially when the underlying issue is something other than straightforward estrogen decline.

Postpartum Dryness

Vaginal dryness after childbirth catches many people off guard because it is rarely discussed in prenatal care. Estrogen drops sharply after delivery, and breastfeeding suppresses it further. A systematic review of topical vaginal estrogen use in postpartum women found that tissue exposed to estrogen showed increased cellular proliferation, and women using vaginal estrogen cream for twelve weeks had lower atrophy scores compared to controls.³⁶ For breastfeeding mothers who prefer to avoid estrogen entirely, over-the-counter moisturizers and lubricants remain the go-to recommendation. The dryness is typically temporary and resolves once breastfeeding ends and hormonal levels recover, but it can be significant enough during that period to warrant active management rather than just waiting it out.